Literature DB >> 31887775

Ly6CLo Monocyte/Macrophages are Essential for Thrombus Resolution in a Murine Model of Venous Thrombosis.

Andrew Scott Kimball1, Andrea Tara Obi1, Catherine E Luke1, Abigail R Dowling1, Qing Cai1, Reheman Adili2, Hannah Jankowski1, Matthew Schaller3, Michael Holinstadt2, Farouc A Jaffer4, Steven L Kunkel5, Katherine A Gallagher1, Peter K Henke1.   

Abstract

Venous thrombosis (VT) resolution is a complex process, resembling sterile wound healing. Infiltrating blood-derived monocyte/macrophages (Mo/MΦs) are essential for the regulation of inflammation in tissue repair. These cells differentiate into inflammatory (CD11b+Ly6CHi) or proreparative (CD11b+Ly6CLo) subtypes. Previous studies have shown that infiltrating Mo/MΦs are important for VT resolution, but the precise roles of different Mo/MΦs subsets are not well understood. Utilizing murine models of stasis and stenosis inferior vena cava thrombosis in concert with a Mo/MΦ depletion model (CD11b-diphtheria toxin receptor [DTR]-expressing mice), we examined the effect of Mo/MΦ depletion on thrombogenesis and VT resolution. In the setting of an 80 to 90% reduction in circulating CD11b+Mo/MΦs, we demonstrated that Mo/MΦs are not essential for thrombogenesis, with no difference in thrombus size, neutrophil recruitment, or neutrophil extracellular traps found. Conversely, CD11b+Mo/MΦ are essential for VT resolution. Diphtheria toxoid (DTx)-mediated depletion after thrombus creation depleted primarily CD11b+Ly6CLo Mo/MΦs and resulted in larger thrombi. DTx-mediated depletion did not alter CD11b+Ly6CHi Mo/MΦ recruitment, suggesting a protective effect of CD11b+Ly6CLo Mo/MΦs in VT resolution. Confirmatory Mo/MΦ depletion with clodronate lysosomes showed a similar phenotype, with failure to resolve VT. Adoptive transfer of CD11b+Ly6CLo Mo/MΦs into Mo/MΦ-depleted mice reversed the phenotype, restoring normal thrombus resolution. These findings suggest that CD11b+Ly6CLo Mo/MΦs are essential for normal VT resolution, consistent with the known proreparative function of this subset, and that further study of Mo/MΦ subsets may identify targets for immunomodulation to accelerate and improve thrombosis resolution. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2019        PMID: 31887775      PMCID: PMC7365023          DOI: 10.1055/s-0039-3400959

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  48 in total

1.  Ly6CHi Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus.

Authors:  Andrew Kimball; Matthew Schaller; Amrita Joshi; Frank M Davis; Aaron denDekker; Anna Boniakowski; Jennifer Bermick; Andrea Obi; Bethany Moore; Peter K Henke; Steve L Kunkel; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-01       Impact factor: 8.311

2.  Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.

Authors:  Adriana Laser; Megan Elfline; Cathy Luke; Dallas Slack; Anuj Shah; Vikram Sood; Barry Deatrick; Brendan McEvoy; Carson Ostra; Anthony Comerota; Steven Kunkel; Cory Hogaboam; Peter K Henke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-05       Impact factor: 8.311

3.  Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model.

Authors:  Peter K Henke; Charles G Pearce; Daria M Moaveni; Andrea J Moore; Erin M Lynch; Christopher Longo; Manu Varma; Nicholas A Dewyer; K Barry Deatrick; Gilbert R Upchurch; Thomas W Wakefield; Cory Hogaboam; Steven L Kunkel
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.

Authors:  Jose A Diaz; Shirley K Wrobleski; Christine M Alvarado; Angela E Hawley; Nichole K Doornbos; Patrick A Lester; Suzan E Lowe; Joy E Gabriel; Karen J Roelofs; Peter K Henke; Robert G Schaub; Thomas W Wakefield; Daniel D Myers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-05       Impact factor: 8.311

5.  Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization.

Authors:  Peter K Henke; Manu R Varma; K Barry Deatrick; Nicholas A Dewyer; Nicholas A Drewyer; Erin M Lynch; Andrea J Moore; Derek A Dubay; Pasu Sukheepod; Charles G Pearce; Gilbert R Upchurch; Steven L Kunkel; Michael G Franz; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2006-02       Impact factor: 5.249

6.  Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage.

Authors:  Che-Feng Chang; Brittany A Goods; Michael H Askenase; Matthew D Hammond; Stephen C Renfroe; Arthur F Steinschneider; Margaret J Landreneau; Youxi Ai; Hannah E Beatty; Luís Henrique Angenendt da Costa; Matthias Mack; Kevin N Sheth; David M Greer; Anita Huttner; Daniel Coman; Fahmeed Hyder; Sourav Ghosh; Carla V Rothlin; J Christopher Love; Lauren H Sansing
Journal:  J Clin Invest       Date:  2017-12-18       Impact factor: 14.808

7.  Novel Markers to Delineate Murine M1 and M2 Macrophages.

Authors:  Kyle A Jablonski; Stephanie A Amici; Lindsay M Webb; Juan de Dios Ruiz-Rosado; Phillip G Popovich; Santiago Partida-Sanchez; Mireia Guerau-de-Arellano
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

Review 8.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

9.  The monocyte to macrophage transition in the murine sterile wound.

Authors:  Meredith J Crane; Jean M Daley; Olivier van Houtte; Samielle K Brancato; William L Henry; Jorge E Albina
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

Review 10.  Immune Factors in Deep Vein Thrombosis Initiation.

Authors:  Ivan Budnik; Alexander Brill
Journal:  Trends Immunol       Date:  2018-05-16       Impact factor: 16.687

View more
  4 in total

1.  Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis.

Authors:  Kelley R Jordan; Cory R Wyatt; Meghan E Fallon; Randy Woltjer; Edward A Neuwelt; Quifang Cheng; David Gailani; Christina Lorentz; Erik I Tucker; Owen J T McCarty; Monica T Hinds; Khanh P Nguyen
Journal:  J Thromb Haemost       Date:  2022-07-18       Impact factor: 16.036

Review 2.  Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation.

Authors:  Marion Pilard; Estelle L Ollivier; Virginie Gourdou-Latyszenok; Francis Couturaud; Catherine A Lemarié
Journal:  Front Cardiovasc Med       Date:  2022-04-21

Review 3.  Inflammation, Infection and Venous Thromboembolism.

Authors:  Meaghan E Colling; Benjamin E Tourdot; Yogendra Kanthi
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

Review 4.  Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.

Authors:  J Matthew Nicklas; Aviva E Gordon; Peter K Henke
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.